Commissioner Nominee's Required Divestitures Illustrate US FDA's Broader Recruitment Challenge

 
• By Derrick Gingery
  
FDABldg1ExteriorWithCircle_1200x675
Stephen Hahn also pledged to give up potential patent royalties should he be confirmed as FDA commissioner. • Source: File photo
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership